ALKIVIA+ is an ongoing open-label extension study that enrolled patients who completed the 24-week, double-blind, placebo-controlled Phase 2 ALKIVIA trial, including those who continued efgartigimod ...

MDS-UPDRS scores remained stable and durable across overall study population after 150 days of treatment with GT-02287Differential response ...

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a ...

Phase three drilling totalling 6,745m underway ・AC rig is on site with RC rig due to commence before quarter end. ・5,000m of ...

Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Fasedienol nasal spray ...

AUSTIN, Texas — With concerns about lead popping up in everything from toys to cookware, many people are looking for quick ways to check for it in their homes. For many people, that means using a ...

Israeli attacks kill three Palestinians, health officials say Police chief and aide in Khan Younis among those killed Israel and Hamas trade blame for violations of October ceasefire Israel's military ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. The first phase of the Los Angeles ...

Euronext has opened the testing phase of its European CSD expansion, as it moves forward with plans to broaden its post-trade offering across the region. Clients are now able to access the testing ...

When you order a new broadcast transmitter, one of the first questions will be about power. Is it single-phase or three-phase alternating current? If single-phase, it is 208 or 240 volts? If it is ...

BOSTON — As a crowd of Philadelphia faithful gathered in a corner of TD Garden, Joel Embiid and Tyrese Maxey emerged from the tunnel to celebrate with their fans following a stunning comeback from a 3 ...

Lian guided to multiple clinical catalysts, saying, "We expect to report the results of this study in the third quarter" (maintenance dosing study) and "Pending clearance, we expect to initiate a ...